Jury sides with AstraZeneca in Nexium pay-for-delay case
MLex Summary: A federal jury in Boston on Friday issued a verdict favorable to AstraZeneca in a case alleging it paid to delay the entry of generic competition to the drug...To view the full article, register now.
Already a subscriber? Click here to view full article